The Global Gene Therapy Market Size is expected to reach USD 49.21 Billion by 2032, at a CAGR of 20.46% during the forecast period 2022 to 2032. Gene therapy involves the introduction, alteration, or replacement of genetic material to treat or prevent various diseases, including inherited genetic disorders, certain types of cancer, and rare conditions.